Products Categories
| CAS No.: | 12232-67-6 |
|---|---|
| Name: | beryllium - titanium (12:1) |
| Molecular Structure: | |
|
|
|
| Formula: | Be12Ti |
| Molecular Weight: | 156.02 |
| Safety: | Confirmed carcinogen with experimental tumorigenic data. See also BERYLLIUM COMPOUNDS and TITANIUM COMPOUNDS. When heated to decomposition it emits very toxic fumes of BeO. |
- 144851-82-1METHYL2-AMINO-3-FLUOROBENZOATE
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 173606-50-3BOC-10-AMINODECANOIC ACID
- 361456-36-2METHYL (R)-(+)-ISOCYANATO-3-PHENYLPROPI&
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- Total:2 Page 1 of 1 1
What can I do for you?
Get Best Price
Chemistry
Product Name: Beryllium, compd. with titanium (12:1) (CAS NO.12232-67-6)
Molecular Formula: Be12Ti
Molecular Weight: 156.02g/mol
Mol File: 12232-67-6.mol
H-Bond Donor: 0
H-Bond Acceptor: 0
IUPAC Name: beryllium; titanium
Canonical SMILES: [Be].[Be].[Be].[Be].[Be].[Be].[Be].[Be].[Be].[Be].[Be].[Be].[Ti]
InChI: InChI=1S/12Be.Ti
InChIKey: MJXQZCUUTKMRPV-UHFFFAOYSA-N
Consensus Reports
IARC Cancer Review: Group 1 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 (1993),p. 41.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 (1993),p. 41.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 1 (1972),p. 17.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 23 (1980),p. 143.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 (1993),p. 41.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . Beryllium and its compounds are on the Community Right-To-Know List.
Safety Profile
Confirmed carcinogen with experimental tumorigenic data. See also BERYLLIUM COMPOUNDS and TITANIUM COMPOUNDS. When heated to decomposition it emits very toxic fumes of BeO.
Standards and Recommendations
OSHA PEL: TWA 0.002 mg(Be)/m3; STEL 0.005 mg(Be)/m3/30M; CL 0.025 mg(Be)/m3
ACGIH TLV: TWA 0.002 mg(Be)/m3; Confirmed Human Carcinogen; (Proposed: TWA 0.0002 mg(Be)/m3 (sensitizer); Confirmed Human Carcinogen)
NIOSH REL: (Beryllium) CL not to exceed 0.0005 mg(Be)/m3
Specification
Beryllium, compd. with titanium (12:1) ,its CAS NO. is 12232-67-6,the synonyms is Titanium compd. with beryllium (1:12) ; CID6338113 ; LS-43512 .